GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,085,000 | +1.4% | 70,869 | +1.5% | 0.66% | -4.3% |
| Q1 2022 | $3,042,000 | +8.1% | 69,832 | +9.4% | 0.69% | +10.5% |
| Q4 2021 | $2,815,000 | +13.7% | 63,834 | -1.5% | 0.63% | -0.8% |
| Q3 2021 | $2,476,000 | +3.8% | 64,804 | +8.2% | 0.63% | +3.4% |
| Q2 2021 | $2,386,000 | +11.7% | 59,919 | +0.1% | 0.61% | +3.2% |
| Q1 2021 | $2,137,000 | +2.8% | 59,879 | +6.0% | 0.59% | -12.8% |
| Q4 2020 | $2,079,000 | +58.1% | 56,484 | +61.6% | 0.68% | +33.4% |
| Q3 2020 | $1,315,000 | -10.1% | 34,947 | -2.5% | 0.51% | -12.7% |
| Q2 2020 | $1,462,000 | +5.8% | 35,847 | -1.7% | 0.58% | -13.0% |
| Q1 2020 | $1,382,000 | -17.7% | 36,477 | +2.0% | 0.67% | +22.5% |
| Q4 2019 | $1,680,000 | +13.1% | 35,757 | +2.7% | 0.55% | +10.7% |
| Q3 2019 | $1,486,000 | +6.3% | 34,827 | -0.3% | 0.49% | +4.9% |
| Q2 2019 | $1,398,000 | -0.9% | 34,937 | +3.4% | 0.47% | -5.0% |
| Q1 2019 | $1,411,000 | +13.5% | 33,772 | +3.8% | 0.50% | -5.2% |
| Q4 2018 | $1,243,000 | -9.5% | 32,527 | -4.9% | 0.52% | -2.8% |
| Q3 2018 | $1,373,000 | +5.7% | 34,192 | +6.1% | 0.54% | +0.9% |
| Q2 2018 | $1,299,000 | +4.9% | 32,222 | +1.7% | 0.53% | -1.7% |
| Q1 2018 | $1,238,000 | +23.6% | 31,692 | +12.2% | 0.54% | +32.8% |
| Q4 2017 | $1,002,000 | -12.9% | 28,252 | -0.4% | 0.41% | -13.4% |
| Q3 2017 | $1,151,000 | +3.7% | 28,352 | +10.1% | 0.47% | -1.9% |
| Q2 2017 | $1,110,000 | +11.1% | 25,747 | +8.7% | 0.48% | +10.6% |
| Q1 2017 | $999,000 | +57.1% | 23,697 | +43.5% | 0.43% | +84.7% |
| Q4 2016 | $636,000 | -29.0% | 16,518 | -20.5% | 0.24% | -32.1% |
| Q3 2016 | $896,000 | +10.1% | 20,774 | +10.6% | 0.35% | +3.6% |
| Q2 2016 | $814,000 | +23.9% | 18,782 | +16.0% | 0.33% | +11.3% |
| Q1 2016 | $657,000 | +26.8% | 16,190 | +26.0% | 0.30% | +20.0% |
| Q4 2015 | $518,000 | -7.3% | 12,845 | -11.7% | 0.25% | -14.1% |
| Q3 2015 | $559,000 | -7.6% | 14,541 | +0.0% | 0.29% | +1.7% |
| Q2 2015 | $605,000 | -21.4% | 14,536 | -12.9% | 0.29% | -21.6% |
| Q1 2015 | $770,000 | +14.8% | 16,686 | +6.3% | 0.36% | +7.4% |
| Q4 2014 | $671,000 | -8.7% | 15,696 | -1.8% | 0.34% | -15.0% |
| Q3 2014 | $735,000 | +16.5% | 15,983 | +35.5% | 0.40% | +22.3% |
| Q2 2014 | $631,000 | +66.1% | 11,793 | +65.8% | 0.33% | +45.3% |
| Q1 2014 | $380,000 | +67.4% | 7,113 | +67.1% | 0.22% | +51.0% |
| Q4 2013 | $227,000 | – | 4,257 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |